A B S T R A C T The metabolism of acetone was studied in lean and obese humans during starvation ketosis. Acetone concentrations in plasma, urine, and breath; and rates of endogenous production, elimination in breath and urine, and in vivo metabolism were determined. There was a direct relationship between plasma acetone turnover (20-77 ,Umol/m2 per min) and concenitration (0.19-1.68 mM). Breath and urinary excretion of acetone accounted for a 2-30% of the endogenous production rate, and in vivo metabolism accounted for the remainder. Plasma acetone oxidation accounted for -60% of the production rate in 3-d fasted subjects and about 25% of the production rate in 21-d fasted subjects. About 1-2% ofthe total CO2 production was derived from plasma acetone oxidation and was not related to the plasma concentration or production rate. Radioactivity from [14C]acetone was not detected in plasma free fatty acids, acetoacetate, ,-hydroxybutyrate, or other anionic compounds, but was present in plasma glucose, lipids, and proteins. If glucose synthesis from acetone is possible in humans, this process could account for 11% of the glucose production rate and 59% of the acetone production rate in 21-d fasted subjects. During maximum acetonemia, acetone productioni from acetoacetate could account for 37% of the anticipated acetoacetate production, which implies that a significant fraction of the latter compound does not undergo immediate terminal oxidation.
INTRODUCTION
The extent to which acetone quantitatively contributes to starvation-induced and diabetic ketonemia has remained controversial for many years. With recently developed methods for acetone determination in blood, breath, and urine, coupled with isotope tracer tech-niques, we have measured rates of endogenous acetone production, breath, and urinary excretion and conversion to other biological compounds during starvationinduced ketonemia in the human. In addition, studies were also done to determine the relationship among plasma acetone, acetoacetate (AcAc),1 and J8-hydroxybutyrate (p-OHB) specific activities during the continuous infusion of [3-14C] AcAc. METHODS Subjects. Clinical data for the 15 volunteer subjects who participated in these studies are shown in Table I . The subjects were of both sexes and ranged in age from 22 to 52 yr. Before admission, the purpose and potential risks of the procedures were discussed with each subject, and informed written consent was obtained. All subjects had normal hemograms, urinalyses, electrocardiograms, chest radiographs, and sequential multiple analyzer (SMA) 12/60 profiles. 2-h postprandial blood glucose concentrations were also normal. During starvation, daily intake consisted of one multivitamin capsule (Unicap, The Upjohn Co., Kalamazoo, Mich.) and at least 1,500 ml of water.
[2-l4C]acetone preparation and administration, sample collection, and analyses. [2-14C] acetone (Amersham Corp., Arlington Heights, Ill.), with a 26 mCi/mmol sp act, was used in all studies. It was dissolved in ice-cold isotonic saline and sterilized by passage through a 0.22-,um Swinnex filter unit (Millipore Corp., Bedford, Mass.). This primary [14C]acetone solution contained 25 ,.LCi/ml.
On the day of the isotope study, the subject was at rest on a bed in a special room equipped with an efficient ventilation system to exhaust exhaled '4CO2 and to maintain a normal room air-gas content. The subject voided before the study, and urine was collected throughout and at the close of the experimental period and stored on ice in a closed container until the appropriate analyses were performed. An antecubital venous catheter was inserted in each arm for administration of the ['4C]acetone and for collection of blood samples.
Immediately before use, an aliquot of the primary [P4C]acetone solution was diluted in a glass syringe with ice-cold isotonic saline, a sample was removed for radiochemical assay, and the remaining solution was rapidly administered intra- ,umol NADH, 3 U ,8-OHB dehydrogenase, and distilled water to make a final vol of 50 ml. After a 2-h incubation period at room temperature, acetone was removed by distillation (1). 30 ,umol of carrier AcAc was added to an aliquot of the distillate and treated as previously described to obtain Denig&'s salt of acetone for counting (2) . Acetone concentration in the distillate was determined by an automated procedure (1) based on the alkaline-salicylaldehyde method of Procos (3) . Radio (4) . AcAc concentrations and acetone concentrations and radioactivity in plasma and urine were determined on the day of study. The determination of acetone concentration in expired air presented special problems because of significant loss of this compound when air collections were made by usual techniques employing Douglas bags. A special device, consisting ofa calibrated 2-liter glass suction flask equipped with a 1.5-cm diameter glass inlet tube, was used. The side arm ofthe suction flask was fitted with a rubber septum through which samples of collected air were removed with Pressure-Lok gas syringes (Supelco, Inc., Bellefonte, Pa.). Breath collections were made by having the subject breathe through the inlet tqbe at a normal rate and volume for 3 min, after which the collecting device was closed. Acetone concentration was determined on 100-to 500-,ul air samples with a gas chromatograph equipped with a flame ionization detector and a 183 cm x 2-mm glass column packed with Carbopack c/0.1% SP-1000 (Supelco, Inc.). Acetone concentration was determined from peak height by comparison with gaseous acetone standards prepared in calibrated 2-liter suction flasks. Acetone output in breath was calculated from the breath acetone concentration and the minute-volume, measured with the Douglas bag technique.
Respiratory gas samples were also obtained simultaneously with each blood sample for analysis of 02, C02, and '4CO2 content (5) . Preliminary studies with prepared air samples containing [14Clacetone showed no contamination of the CO2 trap of the Fredrickson and Ono system (6) which is used in our laboratory to determine CO2 specific activity.
Incorporation of radioactivity into plasma glucose and anionic compounds, including lactate, was estimated with methods previously described (7) . Briefly, this procedure consisted of the preparation of a protein-free filtrate of plasma (8) , the elimination of[14C]acetone from the filtrate by partial evaporation with heat under a stream of nitrogen, and separation of neutral from charged molecules with an Amberlite MB-3 (Rohm and Haas Co., Philadelphia, Pa.) resin column. Glucose in the column eluate was oxidized to gluconic acid with glucose oxidase and isolated for counting purposes with a second column of Amberlite CG-400 resin. Anionic compounds were eluted from the MB-3 column for counting with 0.5 M NaCl.
Total radioactivity in plasma and urine was determined with Bray's solution (9) , in plasma free fatty acids by a previously described method (5) , in plasma total lipids after extraction by the method of Folch et al. (10) , and in plasma proteins after precipitation with 6% perchloric acid. The protein precipitate was washed twice with 6% perchloric acid, extracted by the method of Folch et al. (10) , and the delipidated protein was suspended and counted in Scintisol (Isolab, Inc., Akron, Ohio).
Calculations. After [14C]acetone administration, the linear decline in plasma acetone specific activity with time, which was observed in all subjects, is compatible with first-order reaction-rate kinetics. During each study period, the plasma acetone concentration remained constant, indicating steadystate conditions were present. From the known quantity and specific activity of injected [14C]acetone and the extrapolated zero time plasma acetone specific activity, the acetone pool was calculated. The fractional replacement rate of acetone (k) was obtained with the simplified equation k = 0.693/t112, where t1/2 was determined from the slope ofthe specific activity curve. 620 Reichard, Haff, Skutches, Paul, Holroyde, and Owen (2) . During the infusion period, hourly blood samples were obtained, and plasma acetone, AcAc, and 18-OHB concentrations and specific activities were determined as described.
RESULTS Venous plasma ketone-body concentrations. Table  II shows the mean venous plasma ketone-body concentrations in each group ofsubjects during the isotopetracer study periods. After a 3-d fast, plasma acetone, AcAc, and ,8-OHB concentrations in the nonobese subjects were significantly greater than in the obese subjects. Plasma ketone-body concentratiohs in 21-d fasted obese subjects were also significantly greater than in 3-d fasted obese subjects. In some subjects, plasma acetone concentrations were close to or greater than plasma AcAc concentrations. Plasma AcAc and f3-OHB concentrations were similar to those previously reported for subjects of similar body weights and duration of fast (11) .
Specific activity of plasma acetone, glucose, and PLASMA ACETONE mM FIGURE 2 Relationship between plasma acetone concentration and acetone pool (top panel) or fractional replacement rate (bottom panel). A significant correlation between concentration and pool (r = 0.98, P < 0.001) or concentration and fractional replacement rate (r = 0.67, P < 0.01) was obtained. K% min-', fractional replacement rate.
for this. The bottom panel of Fig. 2 shows an inverse relationship between the fractional replacement rates of the acetone pool and the plasma acetone concentrations.
Acetone turnover rates. Fig. 3 shows the relationship between the acetone turnover rates, expressed as micromoles per square meter per minute, and the plasma acetone concentrations. Values were nor; malized to square meters of body surface area because of the wide range of body weights of the subjects. Although not shown, a similar, highly significant correlation (r = 0.84, P < 0.001) was also obtained when the acetone turnover rate was expressed as micromoles per minute. The mean plasma acetone turnover rate in the 3-d fasted nonobese subjects was 51 (20- The difference between 3-and 21-d fasted obese subjects was statistically significant (P < 0.002).
Urine and breath acetone. The relationship between plasma acetone concentrations and urine or breath concentrations are shown in Fig. 4 . Chemically determined urine acetone concentrations, shown by closed circles in the left panel of Fig. 4 , were obtained from aliquots of pooled urine collected during the 6-h acetone turnover studies, and the plasma acetone concentrations are average values observed in each subject during the same time period. The chemically determined urine acetone concentrations were 10-fold greater than plasma concentrations. However, urine acetone specific activities were considerably less than plasma acetone specific activities, indicating that plasma acetone was not the sole source of urine acetone. At least in part, the lower urine acetone specific activity may have been a result of formation of acetone from unlabeled AcAc in urine during the 6-h collection period. To estimate the fraction of urine acetone derived from plasma, the ratio of urine acetone specific activity to plasma acetone specific activity at the midpoint of each study period was determined. On the basis of these calculations, -8-29% of urine acetone was derived from plasma. Urine acetone concentration, calculated from these percentages and the chemically determined concentrations, are shown as open circles in the left panel of Fig. 4 . Rates of acetone excretion in urine, based on chemically determined and corrected urine acetone concentrations are shown in Table  III . For all subjects, plasma acetone clearance ranged from 0.8 to 2.3 ml/min, suggesting marked renal reabsorption or back-diffusion of the compound.
The relationship between breath and plasma acetone concentrations is shown in the right panel of Fig. 4 . The range of breath acetone concentrations observed in our subjects is similar to that previously reported in fasting humans (12) . Below plasma acetone concentrations of -0.5 mM, ratios of plasma to breath concentrations were in the range of 500:1-600:1, whereas at higher plasma concentrations, the ratios were somewhat smaller, i.e., 350:1-500:1. In the human, after the oral ingestion of acetone, a blood:breath ratio of 330:1 at blood concentrations of 0.5-1.2 mM has been reported (13, 14) .
Metabolic and excretory fate of acetone. Under PLASMA ACETONE mM FIGURE 3 Relationship between plasma acetone concentration and turnover rate. A significant correlation between concentration and turnover rate (r = 0.80, P < 0.001) was obtained. 622 Reichard, Haff, Skutches, Paul, Holroyde, and Owen steady-state conditions, the acetone turnover rate is equal to its rate ofproduction and disappearance. Table  IV shows the percent of the measured acetone production rate which could be accounted for by breath and urinary excretion and, by difference, other in vivo metabolic fates in each subject. In general, the fraction of the acetone production rate accounted for by breath and urinary excretion was directly related to the acetone production rate and plasma concentration. Conversely, the fraction of the acetone production rate accounted for by in vivo metabolism decreased with increasing production rates and plasma concentrations. In all subjects, however, in vivo metabolism was the major mechanism for acetone disposal.2 Similar results have also been obtained in studies in rats and humans after administration of large quantities of nonradioactive acetone (14, 15 Incorporation of radioactivity into plasma glucose was determined in three subjects from each ofthe three groups studied. In each subject, the time-course changes in plasma glucose specific activity was similar to that shown in Fig. 1, i. both fractions increased in a linear manner. After 1 h, plasma lipids contained 1-2% of plasma total radioactivity and, by the 6th h, these values had increased to 2-5%. Radioactivity in plasma proteins was 3-4% of plasma total radioactivity after 1 h and increased to 20-30% after 6 h.
Plasma ketone-body specific activities during [3-14C]-AcAc infusion. To define the relationship among the specific activities of the three plasma ketone bodies and to determine the immediate precursor of plasma acetone, two nonobese subjects were fasted for 3 d and administered [3-14C] AcAc by primed-continuous infusion (2) . Fig. 5 shows time-course changes in plasma acetone, AcAc, and ,-OHB specific activities in one of the subjects, the same pattern being also observed in the other subject. The specific activities of AcAc and ,f-OHB were constant but, unlike previous similar studies (2, [16] [17] [18] , were also equal to each other during the entire experimental period. The Our data show that acetone was present in plasma, urine, and breath of the fasting human in whom appreciable concentrations and rates of endogenous production and use were observed. The concentration of plasma acetone in some subjects was equal to or greater than that of plasma AcAc and also in the range of values recently reported in ketotic diabetic patients (22) .
There was a direct relationship between plasma acetone concentrations and rates of endogenous production with highest concentrations and production rates occurring in two 3-d fasted nonobese subjects and in obese subjects fasted for 21 d. In the latter subjects, the average rate of plasma acetone production was 137 ,umol/min. During fasting, maximum AcAc production rates of about 370 ,umol/min have been reported (11) . Thus, conversion of AcAc to acetone could account for m(137/370) x 100 = 37% of the AcAc produced in the fasting human, implying that a significant fraction of AcAc production may not undergo immediate terminal oxidation.
Depending upon the plasma acetone concentration, excretion of the compound in breath and urine could account for =2-30% of the endogenous acetone production rate (Table IV) . Conversion of acetone to other biological compounds is, therefore, an important disposal mechanism. This is in agreement with previous studies in rats and humans given acetone orally (14, 15) . In our subjects, cumulative 14C02 excretion could account for m5-20% of the administered [I4C]acetone, which suggests that oxidation may play an important role in acetone elimination. Similar conclusions from animal experiments have been reported by others (25) (26) (27) (28) . Approximated rates of acetone oxidation represented-50-70% of the production rates in nonobese and obese 3-d fasted subjects and -25% of the production rates in 21-d fasted obese subjects. Whether acetone is oxidized directly or after conversion to other compounds, such as glucose, cannot be determined from our studies.
The appearance of radioactivity in plasma glucose, lipids, and proteins supports the results of somewhat similar studies in animals in which labeled carbon of acetone was found in cholesterol (25) , liver glycogen (26, 28) , and various amino acids derived from liver and carcass protein (26, 28) . Incorporation ofradioactivity from acetone into glucose suggests the possibility of gluconeogenesis from the compound, or a metabolite(s) of the compound, a process for which evidence has been obtained in rats (28) and ketotic cows (29, 30) . On the basis of our specific activity data, we have calculated that -4-11% of plasma glucose production could theoretically be derived from acetone. The value of 11% was obtained in 21-d fasted obese subjects in whom net splanchnic and renal glucose release rates of =370 ,imol/min might be anticipated (31) . Thus, the rate of glucose production from acetone would be (11/100) x 370 = 40 ,umol/min, requiring 80 ,umol/min glucose equivalents of acetone or 59% of the plasma acetone production rates measured in these subjects. It is recognized that these calculations are based on an unproven assumption that net glucose synthesis from acetone can occur in the human. They were done, however, to gain some insight into the possible importance of this pathway as a mechanism for acetone disposal.
With isotope-tracer techniques, production rates of ketone bodies have been measured in animals (16, 17) and in the human (2, 18) . In many of these studies employing [3-14C] AcAc as the tracer, the calculation of turnover rates was complicated by the lack of isotopic equilibration between AcAc and f3-OHB. Failure to obtain equilibrium was unexpected and difficult to understand. The results of our preliminary studies employing [3-'4C]AcAc infusions suggest that the disequilibrium may have been a result of the presence of unsuspected or incompletely removed [14C]acetone in the AcAc fraction. In these studies, total ketone-body production rates, calculated with the mean specific activity of acetone, AcAc, and ,3-OHB, were 310-15% greater than the values obtained with the mean total ketone-body specific activity as previously reported (2) . Additional studies are required to confirm these observations.
